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Abstract
Genetic variability is a key problem in the prevention and therapy of RNA-based virus infections. Infectious Salmon Anemia
virus (ISAv) is an RNA virus which aggressively attacks salmon producing farms worldwide and in particular in Chile. Just as
with most of the Orthomyxovirus, ISAv displays high variability in its genome which is reflected by a wider infection
potential, thus hampering management and prevention of the disease. Although a number of widely validated detection
procedures exist, in this case there is a need of a more complex approach to the characterization of virus variability. We have
adapted a procedure of High Resolution Melting (HRM) as a fine-tuning technique to fully differentiate viral variants
detected in Chile and projected to other infective variants reported elsewhere. Out of the eight viral coding segments, the
technique was adapted using natural Chilean variants for two of them, namely segments 5 and 6, recognized as virulence-
associated factors. Our work demonstrates the versatility of the technique as well as its superior resolution capacity
compared with standard techniques currently in use as key diagnostic tools.
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Introduction
Infectious Salmon Anemia Virus (ISAv) is a very aggressive
RNA virus which particularly affects salmon fish production in
confined conditions. It was first described in Norway [1], and then
in Canada [2–4], USA [5], Scotland [6], Faroe Islands [7] and
finally in Chile [8,9]. The etiological agent belongs to the family of
the Orthomyxoviridae, the same as that of animal and human
influenza, and to date it is the only reported member of the genus
Isavirus [10,11]. The virus is exclusively restricted to fish and does
not represent a menace to other animal species. The ISAv genome
consists of eight single-stranded RNA segments with negative
polarity coding for at least 10 viral-specific proteins [12,13] and,
as with most orthomyxoviruses, it displays high variability, represent-
ing potential differences in virulence, thus challenging salmon
rearing sustainability. Pathogenicity of this family of viruses, using
influenza as a model [14], seems to be determined by the
interaction of multiple viral-specific coded genes [14], taking as
examples the case for the hemagglutinin [15], the NS1 [16], the
PB1 [17] and the Neuroaminidase proteins [18]. In contrast, the
only confirmed pathogenically associated protein in the ISA virus
is hemagglutinin-esterase (HE), which is encoded in viral segment
6 displaying both receptor binding and receptor destroying
activity [19,20]. In addition, at its C-terminal end HE contains
a highly polymorphic region (HPR) 35 amino acids in length,
close to the transmembrane domain, the target for deletions which
originate all reported virulent variants [21–24]. To date over 30
different HPR variants have been described worldwide and
intriguingly, the variant which contains the complete amino acidic
sequence in the HPR region, named HPR0, is the only variant
reported which does not produce the disease in vivo and it has not
yet been possible to grow in vitro [25–28]. In fact, all virulent ISAv
variants recovered from sick fish as infective units contain
deletions in the HPR region and can be grown in susceptible
cell lines. Recently, the viral fusion protein coded in segment 5
was also associated with virulence [29,30]. This protein is known
to be involved in viral-host cell endosomal membrane fusion. The
protein is synthesized as a precursor F0, which is proteolytically
cleaved to F1 and F2, and held together by disulfide bridges [31].
One of the distinctive features of the coding sequence for the
protein is that it is prone to site-directed transpositional events and
at least four different inserts have been characterized near the
cleavage site of the protein with the distinctive feature that all of
them involve endogenous viral sequences. Of these, insert IN1
derives from viral segment 3, inserts IN2 and IN3 from viral
segment 5 while insert IN4 is derived from viral segment 2 and is
the only one specifically associated with Chilean isolates [25,32].
Although at present there is no clear evidence confirming that
these variations are directly associated with pathogenicity, non-
infectious HPR0 has been reported to contain a key amino acid
(Q at position 266 in the mature F protein, numbering according
sequence EU851044) while virulent forms of the virus contain
amino acid L at this position. This suggests that the change at this
position could be considered as a prerequisite for virulence
development. This evidence also suggests that the presence of Q
plus an insertion might favor the accession to increased virulence
[29].
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virulence of ISAv in vivo, molecular diagnosis is not a simple task.
Of a number of available techniques, detection is primarily carried
out via qRT-PCR [33], which in spite of its unquestionable
advantages, only provides information on the presence or absence
of viral sequences in fish from the field. Notwithstanding, in order
to define which variant you are dealing with, an array of
distinguishing features need to be known in order to properly
characterize each isolate. Thus, it appears to be necessary to
design and develop new strategies to properly and accurately
evaluate variant infectivity as well as to provide relevant
information to improve regulations to sustain confined fish
management.
High Resolution Melting (HRM) is a PCR-based procedure
which works via the inclusion of saturating dyes during the
amplification process [34,35]. This then allows accurate measure-
ment of a fluorescent melting curve as a result of the transition
from double-stranded DNA (dsDNA) to single-stranded DNA
(ssDNA) on the basis of temperature increase. Under these
conditions small variations in the melting patterns of the resulting
amplicons are a reflection of tiny variations in the coding
sequences. HRM has been used widely to type Single Nucleotide
Polymorphism (SNP) [36], differentiate gene mutations [37,38],
detect tandem repeats [39], and to detect and identify microbes
[40–42]. It has also been applied to the characterization and
genotyping analysis of certain RNA viruses such as noro [43],
bursal disease [44] and influenza [45].
In this report we have successfully adapted HRM to differen-
tiate between ISAv segments 5 and 6 as putative virulence-
associated molecular markers, thus constituting a novel comple-
mentary procedure to full differentiation of ISAv variants in Chile.
Results and Discussion
In this study we have used HRM as a novel procedure for
analysis and differentiation of ISAv variants targeting segments
5 and 6 of the virus and focusing on key regions in both segments
which have been associated with virulence [25,29]. Table 1 shows
the characteristics of the resulting amplicons from different
samples analyzed by HRM. Figure 1 shows reported target
nucleotide and amino acidic sequences involved in the analysis for
both segments.
Primer Design
Several sets of primers were designed on the basis of conserving
flanking sequences using those available in the GenBank database
as reference [48]. For segment 5, close to the insertion/cleavage
site; and for segment 6, including the HPR region.
Five primer pairs were tested for segment 5 and six primer pairs
for segment 6. The correct primer choice is critical to increasing
the resolution of the variants since small variations in their
sequences can dramatically affect results. Thus, primer selection is
a pivotal requirement for accuracy and selection was made
according to the keen specificity (single band in agarose gels) and
based on their ability to resolve the different variants available
(Figure 1). Table 1 shows the selected primer sets based upon their
specificity, segregation capacity and accurate reproducibility in the
HRM analyses.
PCR Optimization Conditions
Due to the heterogeneity of the analyzed samples (origin,
infection level, processing batch) and taking into consideration that
HRM is influenced by factors such as salt concentration and DNA
content [49], it was compulsory to perform a primary PCR. This
was done to standardize initial conditions of amplification thus
avoiding bias in the final analysis. All samples were submitted to
the same procedure prior to HRM analysis. In order to project
HRM analysis to field studies, samples with known sequences
should be included in this stage of the analysis.
Variant Identification by Agarose Gel Electrophoresis
Standard DNA electrophoresis analysis is able to resolve
variants in both analyzed segments (Figure 2). For segment 5,
resolution was achieved for variants both containing and not
containing insert IN4. Notwithstanding, this classical technique
was unable to differentiate variants without insertions which also
contain amino acid change Q266RL266, which corresponds to a
nucleotide change ART in the corresponding amplicon
(Figure 2A, lanes 1–2). For segment 6, it was only possible to
differentiate HPR0 (the largest one) from all other deleted variants
(HPR2, HPR5, HPR7b and HPR8), consistently with the small-
size differences in the corresponding amplicons (Figure 2B; lanes
2–5).
Since segment 5 has been reported to contain at least four
different inserts although from different origins with similar sizes,
in the eventuality that any of these should appear in Chile,
standard DNA agarose gel electrophoresis would be unable to
resolve them. In the case of segment 6, due to the existence of a
large number of virulent variants primarily relying on tiny
deletions, the described procedure would most likely also be
Table 1. Characteristics of the amplicons submitted to HRM analysis.
Segment Primer Sequences 59–39 Samples Variant
GenBank Accession
Number Amplicon Size
5 GIM seg5 5F ATGGATGGTCTAAATACAACTTC GF-025 Insert IN4 EU130923 98
GIM seg5 1R ACAGCATTTGATGAACTCTTCTC GF-797 GF-603 No insert Q266 EU851044 65
GF-552 GF-918 No insert L266 GU830907 65
6 GIM seg6 3F TCATGAGGGAGGTAGCATTG GF-797 GF-603* HPR0 EU118820 192
GIM seg6 5R CAATCCCAAAACCTGCTACAC GF-552 HPR2 AF364889 132
GF-041 HPR5 EU625673 129
GF-025 HPR7b FJ594319 123
GF-918 HPR8 AY973192 120
*The sequence is identical to EU118820 except for the single nucleotide change of A to C (Figure 1B *).
doi:10.1371/journal.pone.0037265.t001
ISA Virus Variants Characterized by HRM
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resulting in erroneous interpretation.
Evaluation of the Melting Behavior of Target Samples
A. Under traditional melting curve
measurement. Figure 3 shows the results of our evaluation of
nucleotide changes in the different variants under assessment using
traditional melting peak analyses. For segment 5, and as expected,
it was possible to differentiate insertion-containing sequences from
non-containing. Nonetheless, it was not possible to resolve non-
insertion variants displaying either the A or T nucleotide change
that produces the amino acid change Q266RL266, which in turn is
of putative importance in virulence acquisition (Figure 3A). For
segment 6, it was possible to improve discrimination between
different variants as compared with the limitations encountered
while using agarose electrophoresis (Figure 2B). Among all variants
tested we were able to clearly differentiate the HPR7b variant
from the rest; while the clustered variants HPR2, HPR5 and
HPR8 were found in a very narrow area of Tm value, which
meant it was not possible to resolve them. With HPR0 variants we
were able to differentiate between two single nucleotide changes
displaying two melting peaks: one (HPR0_1) closer to the cluster
HPR2, HPR8 and HPR5 with a low melting peak temperature,
and another, HPR0_2, with a distinguishable higher melting peak
temperature value (Figure 3B). Recall that differentiation between
HPR7b and the others variants, with the exception of the HPR0s,
was not possible using the agarose gel system (Figure 2B). In
summary, traditional melting peak analysis is limited in its ability
to fully resolve most of the HPR variants analyzed. Table 2
summarizes the corresponding experimental peak temperature
values obtained for each variant and although some differentiation
Figure 1. Schematic of nucleotide and amino acid sequences of analyzed viral regions of segments 5 and 6. The number of nucleotides
and amino acids indicated at the end of the sequences correspond to the number inserted in segment 5 and deleted from segment 6. The grey arrow
above the nucleotide sequence in each segment shows the primer locations. The asterisk marks the site of nucleotide change and the black dot
indicates the cleavage site in the fusion protein (segment 5) [46,47].
doi:10.1371/journal.pone.0037265.g001
Figure 2. Amplicons from segments 5 and 6 resolved by
agarose gel DNA electrophoresis. A. Segment 5. L: 100 bp ladder,
1: GF-797 (No insert Q266), 2: GF-552 (No insert L266, 3: GF-025 (Insert
IN4); C-: non template control. B. Segment 6. L: 100 bp ladder, 1: GF-
797 (HPR0_2); 2: GF-552 (HPR2); 3: GF-041 (HPR5); 4: GF-025 (HPR7b);
5:GF-918 (HPR8); C-: non template control.
doi:10.1371/journal.pone.0037265.g002
ISA Virus Variants Characterized by HRM
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reproducible results.
B. Under High Resolution Melting Analysis. In order to
further resolve the minute differences observed in the ISAv
variants analyzed in this work, we considered using HRM as an
alternative and more efficient technique that despite sharing the
same theoretical basis as that described for traditional melting
curve analysis also presents distinguishing features that should
allow enhanced resolution potential for almost identical sequences
[36,50]. HRM uses recent thermocycler technologies, especially
the temperature uniformity between samples, the high rate of
fluorescent data acquisition and highly sophisticated software for
normalization and analysis of the melting curves. In addition,
melting curve analysis is preferred as it uses novel saturating dyes
that display minimal redistribution during the melting process and
because, under these conditions, PCR amplification is not
inhibited [34,35,38,49].
We have achieved better resolution of ISAv variants for segment
5 and 6 using the HRM technique. Figure 4 shows the HRM
analysis of segment 5 which differentiates between variants with
and without the IN4 insertion (Table 1). A much wider resolution
range is observed compared to that obtained using the traditional
melting analysis (Figure 3). This is an important point for diagnosis
in the event that new insertional sequences were to be detected in
Chilean variants, and/or the appearance of those already describe
elsewhere.
Figure 5 shows the corresponding analysis for all segment 6
variants under analysis; it displays highly heterogeneous melting
behavior (Figure 5A). To accurately differentiate between variants
and to improve resolution and visualization of the melting curves,
Figure 3. Comparative traditional melting curve analyses. A: Variants of segment 5. Blue line: GF-797 (No insert Q266), Green Line: GF-552 (No
insert L266), Red Line: GF-025 (Insert IN4). B: Variants of segment 6, Blue Line: GF-797 (HPR0_2); Black Line: GF-603 (HPR0_1); Purple Line: GF-552
(HPR2); Green Line: GF-041 (HPR5); Red Line: GF-025 (HPR7b); Brown Line: GF-918 (HPR8).
doi:10.1371/journal.pone.0037265.g003
Table 2. Experimental Melting Temperature for amplicons in segment 5 and 6.
Segment Melting peak Temperature 6C
5 Insert IN4 No Insert Q266 No insert L266
77.9460.07 76.4560.14 76.3560.00
6 HPR0_1 HPR0_2 HPR2 HPR5 HPR7b HPR8
81.6960.0 81.0260.11 80.2860.10 79.9560.0 78.2060.10 80.4360.10
doi:10.1371/journal.pone.0037265.t002
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HPR7b from the analysis due to its distinguishing and different
Tm value and to cluster variants HPR2, HPR5 and HPR8 plus
the HPR0s, by defining different discriminatory normalization
parameters (Figure 5B).
As in segment 5, HRM provides a higher degree of sensitivity in
resolving the wide range of variability exhibited in viral segment 6.
In the previous methods discussed, it was not possible to resolve
the clustered variants (Figure 3B) while HRM was able to
(Figure 5). It is important to mention that under HRM analysis the
melting curve profiles obtained are not related to the size of the
amplicons, but instead other parameters are more relevant such as
GC content and nucleotide distribution, among others. It is
understandable then that although variants HPR8 and HPR7B,
Figure 4. HRM analysis of segment 5: Upper Panel: Normalized melting curves; Bottom Panel: Differential plot. Red lines: GF-025
(Insert IN4) as baseline. Blue lines: GF-797 (No insert Q266) and Green lines: GF-552 (No insert L266).
doi:10.1371/journal.pone.0037265.g004
Figure 5. HRM analysis of segment 6: Upper Panel: Normalized melting curves; Bottom Panel: Differential plot. A: Analyses of the all
variants available. B: Analysis without considering the sample GF-025. Blue Line: GF-797 (HPR0_2); Black Line: GF-603 (HPR0_1); Purple Line: GF-552
(HPR2); Green Line: GF-041 (HPR5); Red Line: GF-025 (HPR7b); Brown Line: GF-918 (HPR8) used as baseline.
doi:10.1371/journal.pone.0037265.g005
ISA Virus Variants Characterized by HRM
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(Table 1), exhibit completely different HRM profiles (Figure 5).
HPR8 and HPR0_1 variants share similar melting curve profiles,
in spite of the fact that the latter is 72 nucleotides larger than the
former. Nevertheless, two samples from the HPR0 group with a
single nucleotide difference upstream of the HPR region
(Figure 1B) display a difference in behavior under HRM analysis
(Figure 5). A similar case to the single nucleotide change for
identical size amplicons observed for segment 5 could not be
resolved by HRM. In the first case, the change, which involved a
transversion ARC, did affect the melting profile; while in the
second case the similar transversion ART did not. In order to
better understand this situation, we calculated theoretical melting
temperature profiles using an algorithm of EMBOSS [51] over the
amplicon considering each of the four possible nucleotides in the
target site. These results are summarized in Figure 6. In either
case, a change A or T « C or G, modifies the profile, while
changes A « T or, C « G, do not; this is to be expected from the
thermodynamics involved in nucleotide pairing. We conclude that
our theoretical analysis is coherent with our observed experimental
data, suggesting that this dual analysis is projectable to other
putative variants of the ISA virus. We have applied the same
theoretical approach to the existing non-Chilean additional
insertions reported for segment 5 (IN1– IN3), which in spite of
presenting almost the same size, yielded different melting profiles
(data not shown).
After optimization of the HRM analysis with reference samples,
we analyzed about 20 field samples from different farm centers
and sampling dates.
The initial processing of field samples was carried out together
with the reference samples, to ensure uniform conditions and
avoid bias in the analysis. Whereby, every HRM has to be
analyzed independently, therefore standardization parameters
must be modified according to the curves obtained in each test.
Figure 7 shows the HRM curves of field samples for segment 5 and
segment 6. All the variants included were resolved in an optimal
way, in the same way as the reference samples.
In this report we have standardized the HRM technique
specifically to fine-tune resolution between ISA virus variations
exclusive to two of the most important segments associated with
viral pathogenesis. It was possible to distinguish variants that have
a difference in the melting temperature of only 0.15uC, as was the
case with variants HPR2 and HPR8 (Table 2), which could not be
separated by agarose gel or by traditional melting curve analysis.
The relevancy of the described technique should enable us to
face two situations that might involve the highly variable ISAv: the
coexistence of two variants in the same fish from field samples,
which at present cannot be easily assessed; the appearance of new
variants that might threaten the sustainability of the sector. We
foresee that widening the application of the technique could be
applicable to identifying variability in other segments of the ISA
virus, allowing the construction of a highly necessary genetic
profile of this aggressive virus. Finally, HRM allows evaluation of
large numbers of samples as a presequencing screening technique.
Although it does not replace DNA sequencing as a gold standard
technique in differentiation between variants, HRM stands as an
amicable and useful technique for determining which of many
samples are recommendable for sequencing.
Materials and Methods
Fish Samples
The analyzed variants are organ pools (kidney, heart and gills)
from naturally infected Salmo salar specimens, which were
confirmed as positive by qRT-PCR [33] in our laboratory.
Samples were collected at different times as well as from different
locations from Southern Chile.
ISA Virus Variants
The selected regions from segments 5 and 6 were sequenced
(Macrogene Inc. Korea) and compared by Blast against sequences
available in the GenBank database (Table 3).
RNA Extraction
The organ pool samples were preserved in RNAlater (Ambion,
USA) and extracted for RNA using the column-based purification
method RNeasy Mini Kits (Qiagen, USA) in accordance with the
standard protocols recommended by the supplier. Samples were
then stored at 280uC.
cDNA Synthesis
cDNAs were obtained through the SuperScript III reverse
transcriptase (Invitrogen, USA) using random hexamer as primer
(Fermentas, USA) with 1 mg of RNA in accordance with
manufacturer’s instructions. Reverse transcription was performed
initially with a 10 min incubation at 25uC, followed by 1 h
incubation at 50uC and enzyme inactivation at 72uC for 15 min.
Figure 6. Theoretical melting profiles. A. Segment 5. B. Segment 6. Melting profiles are superimposed except for the region influenced by the
nucleotide change.
doi:10.1371/journal.pone.0037265.g006
ISA Virus Variants Characterized by HRM
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The RNA sequences of the ISAV variants for segments 5 and 6
were obtained from GenBank database [48] using the BioEdit
alignment editor [52] to find highly conserved regions in order to
then design specific primers that were able to produce short
amplicons. Primer 3 software [53] was used and some manual
adjustments made when required, and primer properties were
calculated with OligoCalc [54] which were designed outside the
analyzed region for segment 5 and segment 6. For segment 5,
GIM SEG-5 Ext-F (59 TAC AAC GGA AAG GAT TAA GAC
TG 39) and GIM SEG-5 Ext-R (59 TCT CCT TCT AGC AGC
AGG TTC 39). For Segment 6, GIM SEG-6 4F (59 GCC CAG
ACA TTG ACT GGA GTA G 39) and GIM SEG-6 1R (59 CTC
TAG ACT TGT ACA TGA ATG CTG 39).
Figure 7. HRM analysis of field samples. A. Diferential plot of segment 5 insertion region: Red Line (IN4 insertion) as baseline, Blue Line (No
insert Q266) and Green lines: GF-552 (No insert L266). B. Diferential plot of segment 6 deletion regions: Blue Line: GF-797 (HPR0_2); Purple Line: GF-552
(HPR2); Green Line: GF-041 (HPR5); Red Line: GF-025 (HPR7b); Brown Line: GF-918 (HPR8) used as baseline.
doi:10.1371/journal.pone.0037265.g007
Table 3. Variants for each sample and their corresponding access number.
Samples Segment 5 Variant
GenBank Accession numbers of
Segment 5 Segment 6 Variant
GenBank Accession numbers of
Segment 6
GF-025 Insert IN4 EU130923 HPR7b FJ594319
GF-552 No insert L266 GU830907 HPR2 AF364889
GF-918 No insert L266 GU830907 HPR8 AY973192
GF-041 Not sequenced –––––– HPR5 EU625673
GF-603{ No insert Q266 EU851044 HPR0_1 EU118820
GF-797 No insert Q266 EU851044 HPR0_2 EU118820
doi:10.1371/journal.pone.0037265.t003
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2 mL of every cDNA was added to the reaction mixture with
a final volume of 12.5 mL containing 2 mM MgCl2,1 XG o
Taq Buffer, 0.5 U Go taq enzyme (Promega, USA), 0.2 mM
each dNTPs (Promega, USA), and 0.5 mM of each primer. The
cycling conditions were 1 cycle of the initial denaturation at
95uC for 2 min, then 35 cycles at 95uC for 30 s, followed by
primer annealing at 60uC for 30 s and an extension step at
72uC for 1 min. A final extension cycle was obtained for 5 min
at 72uC.
The product of this amplification was diluted 1000 times to be
used in the amplification through real-time PCR and the High
Resolution Melting curve analyses were then performed.
Agarose Electrophoresis
Every PCR-amplified sample was resolved by 2% (w/v) agarose
gel electrophoresis in a horizontal eletrophoresis chamber at
100 V for 30 min and visualized in GelRed stained gels
(PhotoCapture; DNR Bio-imaging System, Ltd. Israel).
Traditional Melting Curve Analyses
This analysis was performing in a Real time thermocycler Step
OnePlus (Applied Biosystems. USA). The procedure was carried
out using the same protocols, reagents and temperature program
used for the secondary real-time PCR and HRM analysis (detailed
in the next section). The traditional melting curve measurements
were performed using fluorescent data acquisition every 0.3uC.
The analysis was carried out by derivative melting curve plot. The
melting peak temperature determination was performed with the
Applied Biosystem StepOne v2.2 software.
Secondary Real-Time PCR and HRM Curve Analysis
Real–time PCR amplification and acquisiton of the HRM curve
was carried out with the thermocycler LightCycler 2.0 (Roche
Diagnostics, Germany). The reagent mix was prepared with 2 mLo f
the diluted primary PCR, 2.5 mM MgCl2, 1X LightCycler 480
HRM master mix (Roche, Germany), 200 nM of each primer, in a
final reaction volumen of 20 mL. PCR cycles were performed under
the following conditions: 1 cycle at 95uC for 10 min; 40 cycles at
95uC for 10 s, 60uC for 10 s, and 72uC for 20 s. The amplicons
were melted by raising the temperature from 70uCt o9 0 uC, with an
increment of 0.05uC/s and fluorescence was continuously acquired,
in order to obtain information on melting profiles.
The analysis of the HRM curve was performed using the
LightCycler 480 gene-scanning Software v1.5. This software
analyzes the HRM curve data to identify the shape of the curve
and the Tm differences. The software employs a three-step
analysis. The first step is to normalize the raw melting-curve data
by setting the pre-melt (initial fluorescence) and post-melt (final
fluorescence) signals of all samples to uniform values. Pre-melt
signals are uniformly set to a relative value of 100%, while post-
melt signals are set to a relative value of 0%. The normalization
parameters used are summarized in Table 4. The second step is to
shift the temperature along the X-axis of the normalized melting
curves at the point where the entire double stranded DNA is
completely denatured. The third step is to further analyze the
differences in melting-curve shape by subtracting the curves from a
reference curve (also called the ‘‘baseline’’). Thus generating a
difference plot, accentuating the changes in the shapes of the
melting curves [43].
Due to the diversity of the samples, the first parameter to
discriminate between the variants was the Tm value.
We carried out the first and third step of the software analysis
independently. The second step, which unifies the final melting
temperature, is used mainly in HRM applications to identify
heterozygosity [49]. In the present study, the presence of insertions
or deletions in the samples was sufficient to produce a temperature
change. Nevertheless, if it is necessary to differentiate minimal
changes between two sequences with the same Tm it will be
necessary to perform this step to improve resolution.
Theoretical Calculation of Melting Temperature Profiles
For theoretical melting profiles we used the application Dan of
EMBOSS suite [51], through Mobyle portal [55]. The melting
profile is calculated as the average within a sliding window taking
into account the thermodynamic behavior of the nearest neighbor
[56,57]. We chose a 20 nucleotide window as reference. For both
segments, 5 and 6, the target position was replaced by each of the
four nucleotides (ATGC), and the resulting profiles are shown in
Figure 6.
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